| Literature DB >> 30078031 |
Changhai Xu1, Zhe Wang2, Kaining Lu3, Hongxu Jin1.
Abstract
Sepsis is a common life-threatening pathological process. However, the transformation efficiency of studies on the treatment of sepsis is relatively low. Therefore, a hotspot and trend development study was attempted on the treatment area of sepsis in accordance with the literature. We selected 2511 studies most related to the treatment of sepsis within the past 5 years as research samples. Text and co-word matrix were established by analyzing and selecting high-frequency words using BICOMB software. Classifications in hotspot areas were obtained through biclustering and visual analysis of high-frequency words using Ggluto software. Strategy coordinates for hotspot research were conducted using a co-word matrix. A total of 41 high-frequency words, text, and co-word matrix were conducted within the 2511 studies. A peak map was drawn based on biclustering analysis. The density and concentricity of each hotspot were calculated using the result of the co-word matrix and biclustering analysis. The research concluded 4 categories and 9 aspects for the treatment of sepsis. Additionally, calculation results showed that the relationship between the prognosis of sepsis and the hematological prognosis was in the fourth quadrant of the strategic diagram, that means it was the potential hotspot area for the treatment of sepsis. This conclusion provides potential value for future exploratory stages of study.Entities:
Mesh:
Year: 2018 PMID: 30078031 PMCID: PMC6091165 DOI: 10.12659/MSM.908950
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Highly frequent major MeSH terms from the included publications on sepsis and therapeutics (n=3738).
| No. | MeSH terms | Frequency n (%) | Cumulative percentage, % |
|---|---|---|---|
| 1 | Sepsis/therapy | 474 (3.60) | 3.6024 |
| 2 | Shock, septic/therapy | 308 (2.34) | 5.9432 |
| 3 | Catheterization, central venous/adverse effects | 222 (1.69) | 7.6303 |
| 4 | Anti-bacterial agents/therapeutic use | 182 (1.38) | 9.0135 |
| 5 | Fluid therapy/methods | 150 (1.14) | 10.1535 |
| 6 | Bacteremia/prevention & control | 147 (1.12) | 11.2707 |
| 7 | Sepsis/drug therapy | 145 (1.10) | 12.3727 |
| 8 | Sepsis/diagnosis | 139 (1.06) | 13.4291 |
| 9 | Sepsis/prevention & control | 137 (1.04) | 14.4703 |
| 10 | Sepsis/epidemiology | 123 (0.93) | 15.4051 |
| 11 | Bacteremia/epidemiology | 123 (0.93) | 16.3399 |
| 12 | Sepsis/mortality | 122 (0.93) | 17.2671 |
| 13 | Resuscitation/methods | 116 (0.88) | 18.1487 |
| 14 | Catheter-Related Infections/prevention & control | 108 (0.82) | 18.9694 |
| 15 | Sepsis/etiology | 103 (0.78) | 19.7522 |
| 16 | Catheter-related infections/epidemiology | 99 (0.75) | 20.5046 |
| 17 | Critical care/methods | 93 (0.71) | 21.2114 |
| 18 | Fluid therapy | 87 (0.66) | 21.8726 |
| 19 | Critical care | 74 (0.56) | 22.435 |
| 20 | Shock, septic/mortality | 71 (0.54) | 22.9746 |
| 21 | Cross infection/prevention & control | 71 (0.54) | 23.5142 |
| 22 | Hospitalization/statistics & numerical data | 67 (0.51) | 24.0234 |
| 23 | Bacteremia/etiology | 67 (0.51) | 24.5326 |
| 24 | Anti-bacterial agents/administration & dosage | 66 (0.50) | 25.0342 |
| 25 | Bacteremia/microbiology | 65 (0.49) | 25.5282 |
| 26 | Hospital mortality | 63 (0.48) | 26.007 |
| 27 | Sepsis/complications | 62 (0.47) | 26.4782 |
| 28 | Sepsis/blood | 57 (0.43) | 26.9114 |
| 29 | Bacteremia/drug therapy | 57 (0.43) | 27.3446 |
| 30 | Shock, septic/drug therapy | 56 (0.43) | 27.7702 |
| 31 | Intensive Care Units | 54 (0.41) | 28.1806 |
| 32 | Kidney transplantation/adverse effects | 53 (0.40) | 28.5834 |
| 33 | Renal dialysis/adverse effects | 52 (0.40) | 28.9786 |
| 34 | Sepsis/immunology | 49 (0.37) | 29.351 |
| 35 | Cross infection/epidemiology | 46 (0.35) | 29.7006 |
| 36 | Catheterization, central venous/methods | 45 (0.34) | 30.0426 |
| 37 | Critical care/standards | 45 (0.34) | 30.3846 |
| 38 | Clinical protocols | 44 (0.33) | 30.719 |
| 39 | Vasoconstrictor agents/therapeutic use | 44 (0.33) | 31.0534 |
| 40 | Catheter-related infections/etiology | 43 (0.33) | 31.3801 |
| 41 | Sepsis/physiopathology | 43 (0.33) | 31.7069 |
Highly frequent major MeSH terms-source articles matrix (localized).
| No. | Major MeSH terms | PubMed Unique Identifiers of source article | ||||
|---|---|---|---|---|---|---|
| 19800754 | 20807391 | 21195419 | … | 28591533 | ||
| 1 | Sepsis/therapy | 0 | 0 | 0 | … | 0 |
| 2 | Shock, septic/therapy | 0 | 0 | 0 | … | 1 |
| 3 | Catheterization, central venous/adverse effects | 0 | 0 | 0 | … | 0 |
| 4 | Anti-bacterial agents/therapeutic use | 0 | 0 | 0 | … | 0 |
| … | … | … | ||||
| 40 | Catheter-related infections/etiology | 0 | 0 | 0 | … | 0 |
| 41 | Sepsis/physiopathology | 0 | 0 | 0 | … | 0 |
Figure 1A mountain visualization biclustering of highly frequent major MeSH terms and articles on sepsis and therapeutics.
Figure 2A visualized matrix biclustering of highly frequent major MeSH terms and PubMed Unique Identifiers (PMIDs) of articles on sepsis and therapeutics.
Descriptive and discriminating features.
| Descriptive and descriminating features | |||||
|---|---|---|---|---|---|
| Cluster 0 | size 8 | ||||
| Descriptive: | 23577195 | 23651883 | 23651884 | 23375574 | |
| Descriminating | 23577195 | 24237085 | 24329640 | 24329641 | |
| Cluster 1 | size 11 | Isim: 0.0198 | Esim: 0.013 | ||
| Descriptive: | 22645119 | 25986020 | 27104606 | 24177238 | |
| Descriminating | 22645119 | 25986020 | 27104606 | 24177238 | |
| Cluster 2 | size 10 | Isim: 0.0190 | Esim: 0.016 | ||
| Descriptive: | 24275413 | 24275412 | 26280432 | 26244317 | |
| Descriminating | 28320242 | 25180196 | 26280432 | 26244317 | |
| Cluster 3 | size 11 | Isim: 0.0198 | Esim: 0.013 | ||
| Descriptive | 25344412 | 27133236 | 25479113 | 25700057 | |
| Descriminating | 25344412 | 25830524 | 25398103 | 25830525 | |
The centrality and density of the 4 clusters.
| Cluster | Intra-class link averages | Density-Y | Inter-class link average | Centrality-X |
|---|---|---|---|---|
| 0 | 19.125 | −2.14084596 | 1.534090909 | −0.235601215 |
| 1 | 21.4 | 0.13415404 | 1.372727273 | −0.396964852 |
| 2 | 31.47777778 | 10.21193182 | 2.048387097 | 0.278694973 |
| 3 | 13.06060606 | −8.205239899 | 2.123563218 | 0.353871094 |
| Average | 21.26584596 | 1.769692124 |
Figure 3A strategic diagram of the clusters.